SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:SVS • IT0005469264

8.52 EUR
-0.08 (-0.93%)
Last: Feb 4, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SVS. SVS was compared to 63 industry peers in the Health Care Equipment & Supplies industry. SVS has only an average score on both its financial health and profitability. SVS is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • SVS had positive earnings in the past year.
  • In the past year SVS has reported a negative cash flow from operations.
  • Each year in the past 5 years SVS has been profitable.
  • Each year in the past 5 years SVS had a positive operating cash flow.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

  • The Return On Assets of SVS (3.75%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 10.43%, SVS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Return On Invested Capital of SVS (8.04%) is better than 65.08% of its industry peers.
  • SVS had an Average Return On Invested Capital over the past 3 years of 6.63%. This is below the industry average of 9.98%.
  • The 3 year average ROIC (6.63%) for SVS is below the current ROIC(8.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROIC 8.04%
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • SVS has a Profit Margin (5.09%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of SVS has grown nicely.
  • SVS has a Operating Margin (8.71%) which is in line with its industry peers.
  • SVS's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 26.17%, SVS is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
  • SVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • SVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, SVS has less shares outstanding
  • Compared to 5 years ago, SVS has less shares outstanding
  • SVS has a better debt/assets ratio than last year.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 1.81, we must say that SVS is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.81, SVS is doing worse than 61.90% of the companies in the same industry.
  • SVS has a Debt/Equity ratio of 0.62. This is a neutral value indicating SVS is somewhat dependend on debt financing.
  • SVS has a Debt to Equity ratio of 0.62. This is in the lower half of the industry: SVS underperforms 65.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 1.81
ROIC/WACC1.14
WACC7.08%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that SVS should not have too much problems paying its short term obligations.
  • SVS has a better Current ratio (1.82) than 61.90% of its industry peers.
  • SVS has a Quick Ratio of 1.34. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
  • SVS has a better Quick ratio (1.34) than 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.34
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
  • Measured over the past years, SVS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.97% on average per year.
  • Looking at the last year, SVS shows a quite strong growth in Revenue. The Revenue has grown by 9.07% in the last year.
  • SVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.34% yearly.
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%

3.2 Future

  • Based on estimates for the next years, SVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.83% on average per year.
  • SVS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.07% yearly.
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • SVS is valuated cheaply with a Price/Earnings ratio of 6.71.
  • Based on the Price/Earnings ratio, SVS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 28.23. SVS is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 5.78, which indicates a rather cheap valuation of SVS.
  • 96.83% of the companies in the same industry are more expensive than SVS, based on the Price/Forward Earnings ratio.
  • SVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.01.
Industry RankSector Rank
PE 6.71
Fwd PE 5.78
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SVS is valued cheaper than 93.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.66
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SVS's earnings are expected to grow with 14.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)0.34
EPS Next 2Y17.92%
EPS Next 3Y14.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.93%, SVS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.97, SVS pays a better dividend. On top of this SVS pays more dividend than 95.24% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.79, SVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.93%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 19.64% of the earnings are spent on dividend by SVS. This is a low number and sustainable payout ratio.
DP19.64%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
SVS.MI Dividend Payout.SVS.MI Dividend Payout, showing the Payout Ratio.SVS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SVAS BIOSANA SPA

BIT:SVS (2/4/2026, 7:00:00 PM)

8.52

-0.08 (-0.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap47.71M
Revenue(TTM)132.55M
Net Income(TTM)6.74M
Analysts80
Price Target17.44 (104.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.93%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP19.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.93%
PT rev (3m)15.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.71
Fwd PE 5.78
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 1.02
EV/EBITDA 4.66
EPS(TTM)1.27
EY14.91%
EPS(NY)1.47
Fwd EY17.31%
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS23.67
BVpS11.54
TBVpS8.36
PEG (NY)0.2
PEG (5Y)0.34
Graham Number18.16
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 10.43%
ROCE 10.81%
ROIC 8.04%
ROICexc 10.91%
ROICexgc 14.1%
OM 8.71%
PM (TTM) 5.09%
GM 26.17%
FCFM N/A
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
ROICexc(3y)10.45%
ROICexc(5y)9.43%
ROICexgc(3y)12.81%
ROICexgc(5y)11.57%
ROCE(3y)8.91%
ROCE(5y)8.53%
ROICexgc growth 3Y10.44%
ROICexgc growth 5Y8.61%
ROICexc growth 3Y11.05%
ROICexc growth 5Y7.72%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA 2.36
Cap/Depr 113.41%
Cap/Sales 4.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.34
Altman-Z 1.81
F-Score5
WACC7.08%
ROIC/WACC1.14
Cap/Depr(3y)111.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
Revenue Next Year19.23%
Revenue Next 2Y11.86%
Revenue Next 3Y9.07%
Revenue Next 5YN/A
EBIT growth 1Y17.64%
EBIT growth 3Y17.79%
EBIT growth 5Y14.69%
EBIT Next Year94.24%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y-245.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.92%
OCF growth 3Y26.58%
OCF growth 5Y-3.68%

SVAS BIOSANA SPA / SVS.MI FAQ

What is the ChartMill fundamental rating of SVAS BIOSANA SPA (SVS.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SVS.MI.


Can you provide the valuation status for SVAS BIOSANA SPA?

ChartMill assigns a valuation rating of 7 / 10 to SVAS BIOSANA SPA (SVS.MI). This can be considered as Undervalued.


How profitable is SVAS BIOSANA SPA (SVS.MI) stock?

SVAS BIOSANA SPA (SVS.MI) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SVAS BIOSANA SPA (SVS.MI) stock?

The Price/Earnings (PE) ratio for SVAS BIOSANA SPA (SVS.MI) is 6.71 and the Price/Book (PB) ratio is 0.74.


Is the dividend of SVAS BIOSANA SPA sustainable?

The dividend rating of SVAS BIOSANA SPA (SVS.MI) is 6 / 10 and the dividend payout ratio is 19.64%.